1-5 of 5
Xingguo Liu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

HZ-R061, a Selective STAT3 Degrader with Activity in Preclinical Model of Hematologic Malignances

Yizhe Wu, Xingguo Liu, Xinxin Jin, Jiangfeng Xie, Haiyan Yang, Xinglu Zhou
Journal: Blood
Blood (2022) 140 (Supplement 1): 7818.
https://doi.org/10.1182/blood-2022-167261
Published: 2022
Journal Articles

Discovery and Preclinical Study of Novel BTK Degrader HZ-Q1060

Xingguo Liu, Yubo Zhou, Yizhe Wu, Xiaomin Luo, Jiangfeng Xie, Xinxin Jin, Haiyan Yang, Li Jia, Xinglu Zhou
Journal: Blood
Blood (2022) 140 (Supplement 1): 4942.
https://doi.org/10.1182/blood-2022-167308
Published: 2022
Journal Articles

Discovery of HZ-L105, a Next Generation of Bcl-2 Inhibitor, Overcomes Bcl-2 Mutation and Exhibits Superior Antitumor Activity

Xingguo Liu, Yang Lou, Yizhe Wu, Mingbo Su, Anhui Gao, Jinglai Huang, Haiyan Yang, Li Zhong, Xinglu Zhou
Journal: Blood
Blood (2022) 140 (Supplement 1): 7798–7799.
https://doi.org/10.1182/blood-2022-166997
Published: 2022
Journal Articles

Dual CK1ε/PI3Kδ Inhibitor HZ-H08905, Exhibits As a Potential Therapeutic Strategy for Hematologic Malignancies

Juying Wei, Wenjuan Yu, Hongyan Tong, Min Yang, Miao Hu, Xingguo Liu, Yizhe Wu, Xinglu Zhou, Jie Jin
Journal: Blood
Blood (2022) 140 (Supplement 1): 12065.
https://doi.org/10.1182/blood-2022-165195
Published: 2022
Journal Articles

HZ-a-018 Is a Highly Selective and Potent BTK Inhibitor with CNS-Penetrating Profile for Central Nervous System Lymphoma

Zhuang Kang, Feng Chen, Yi Lin, Xianggui Yuan, Xi Chen, Wenbin Qian, Haiyan Yang, Miao Hu, Xingguo Liu, Xinglu Zhou, Wenbin Li
Journal: Blood
Blood (2022) 140 (Supplement 1): 12064.
https://doi.org/10.1182/blood-2022-166776
Published: 2022